Download answer_key/T03.json from hedwigai/model-bench-v2: direct link, hf CLI and curl.
- Browser
- Download file 11.7 kB
-
https://huggingface.co/datasets/hedwigai/model-bench-v2/resolve/main/answer_key/T03.json
- Command line
-
hf download hf://datasets/hedwigai/model-bench-v2/answer_key/T03.json
-
curl -L -o T03.json https://huggingface.co/datasets/hedwigai/model-bench-v2/resolve/main/answer_key/T03.json
11.7 kB
| { | |
| "task": "T03 Form D biotech, filed 2026-10-26..2026-11-10, sold >= $1,000,000", | |
| "expected_count": 8, | |
| "method": "Enumerated from EDGAR itself: every D and D/A in the daily form indexes https://www.sec.gov/Archives/edgar/daily-index/2026/QTR4/form.YYYYMMDD.idx for 20261026-20261110 (2,891 Form D/D/A accessions; EDGAR closed 2026-11-11), each primary_doc.xml parsed for submissionType, industryGroupType, issuerAddress, totalAmountSold, dateOfFirstSale. 42 Biotechnology filings in window; EDGAR full-text search (efts.sec.gov, forms=D, q=\"Biotechnology\", same dates) independently returns exactly 42 hits — the same set.", | |
| "scoring": { | |
| "row_correct_if": "issuer + amount sold + filing date exact; city/state are the Form D issuer address (NOT the EDGAR filer-profile address: Zai Lab's filer profile says Shanghai, its Form D says Cambridge MA)", | |
| "excluded_on_purpose": { | |
| "D/A amendments >= $1M in window": [ | |
| "Elucid Bioimaging 56,235,000 (10-27)", | |
| "Gut-Brain-Axis Therapeutics 1,965,000 (10-27)", | |
| "Nuclein LLC 15,650,488 debt (10-27)", | |
| "BioLattice Ophthalmics 1,825,000 (10-28)", | |
| "28bio 8,524,945 (10-29)", | |
| "Trellis Bioscience 9,093,000 (10-29)", | |
| "ARC Medical 1,623,382 (11-10)", | |
| "InSitu Biologics 15,037,850 (11-10)" | |
| ], | |
| "duplicate": "AI3 Bio filed two D notices on 11-04; -000004 reports $0 sold — exclude", | |
| "under threshold examples": [ | |
| "EVIA Life Sciences 700,002", | |
| "511 Therapeutics 500,000", | |
| "Frontier Bio 380,000", | |
| "Conexeu Sciences 21,645 and 4,801 (two notices 11-05)" | |
| ] | |
| }, | |
| "program_note": "`funding recent biotechnology` (run 2026-11-12) read 28 of 31 filings since 2026-10-13 and returned only Zai Lab and Chickadee of these 8 rows — a model that trusts it alone will miss 6." | |
| }, | |
| "rows": [ | |
| { | |
| "company": "BigHat Biosciences, Inc.", | |
| "city": "San Mateo", | |
| "state": "CA", | |
| "amount sold usd": 75141086, | |
| "first sale": "2026-07-17", | |
| "filed on": "2026-10-26", | |
| "securities": "equity", | |
| "EDGAR link": "https://www.sec.gov/Archives/edgar/data/1797256/000123191926001499/0001231919-26-001499-index.htm", | |
| "sources": [ | |
| { | |
| "kind": "primary", | |
| "url": "https://www.sec.gov/Archives/edgar/data/1797256/000123191926001499/primary_doc.xml", | |
| "quote": "submissionType D; industryGroupType Biotechnology; issuerAddress city SAN MATEO CA; totalAmountSold 75141086; dateOfFirstSale 2026-07-17" | |
| }, | |
| { | |
| "kind": "other", | |
| "url": "https://efts.sec.gov/LATEST/search-index?q=%22Biotechnology%22&forms=D&dateRange=custom&startdt=2026-10-26&enddt=2026-11-10", | |
| "quote": "hit 0001231919-26-001499: form D, file_date 2026-10-26" | |
| } | |
| ], | |
| "single_source_fields": [ | |
| "amount sold usd", | |
| "first sale" | |
| ], | |
| "single_source_reason": "Only the Form D itself states amount sold and first-sale date; EFTS confirms form type, filing date and issuer, not amounts." | |
| }, | |
| { | |
| "company": "Accufy Diagnostics, Inc.", | |
| "city": "Rockville", | |
| "state": "MD", | |
| "amount sold usd": 2000000, | |
| "first sale": "2026-10-15", | |
| "filed on": "2026-10-28", | |
| "securities": "equity", | |
| "EDGAR link": "https://www.sec.gov/Archives/edgar/data/2089723/000208972326000001/0002089723-26-000001-index.htm", | |
| "sources": [ | |
| { | |
| "kind": "primary", | |
| "url": "https://www.sec.gov/Archives/edgar/data/2089723/000208972326000001/primary_doc.xml", | |
| "quote": "submissionType D; industryGroupType Biotechnology; issuerAddress city ROCKVILLE MD; totalAmountSold 2000000; dateOfFirstSale 2026-10-15" | |
| }, | |
| { | |
| "kind": "other", | |
| "url": "https://efts.sec.gov/LATEST/search-index?q=%22Biotechnology%22&forms=D&dateRange=custom&startdt=2026-10-26&enddt=2026-11-10", | |
| "quote": "hit 0002089723-26-000001: form D, file_date 2026-10-28" | |
| } | |
| ], | |
| "single_source_fields": [ | |
| "amount sold usd", | |
| "first sale" | |
| ], | |
| "single_source_reason": "Only the Form D itself states amount sold and first-sale date; EFTS confirms form type, filing date and issuer, not amounts." | |
| }, | |
| { | |
| "company": "Swep Bio, Inc.", | |
| "city": "Scarsdale", | |
| "state": "NY", | |
| "amount sold usd": 2499989, | |
| "first sale": "2026-10-28", | |
| "filed on": "2026-10-29", | |
| "securities": "equity", | |
| "EDGAR link": "https://www.sec.gov/Archives/edgar/data/2159106/000215910626000001/0002159106-26-000001-index.htm", | |
| "sources": [ | |
| { | |
| "kind": "primary", | |
| "url": "https://www.sec.gov/Archives/edgar/data/2159106/000215910626000001/primary_doc.xml", | |
| "quote": "submissionType D; industryGroupType Biotechnology; issuerAddress city SCARSDALE NY; totalAmountSold 2499989; dateOfFirstSale 2026-10-28" | |
| }, | |
| { | |
| "kind": "other", | |
| "url": "https://efts.sec.gov/LATEST/search-index?q=%22Biotechnology%22&forms=D&dateRange=custom&startdt=2026-10-26&enddt=2026-11-10", | |
| "quote": "hit 0002159106-26-000001: form D, file_date 2026-10-29" | |
| } | |
| ], | |
| "single_source_fields": [ | |
| "amount sold usd", | |
| "first sale" | |
| ], | |
| "single_source_reason": "Only the Form D itself states amount sold and first-sale date; EFTS confirms form type, filing date and issuer, not amounts." | |
| }, | |
| { | |
| "company": "Tru Singular Health, Inc.", | |
| "city": "Natick", | |
| "state": "MA", | |
| "amount sold usd": 1000000, | |
| "first sale": "2026-09-01", | |
| "filed on": "2026-10-30", | |
| "securities": "security to be acquired / other", | |
| "EDGAR link": "https://www.sec.gov/Archives/edgar/data/2158834/000215883426000001/0002158834-26-000001-index.htm", | |
| "sources": [ | |
| { | |
| "kind": "primary", | |
| "url": "https://www.sec.gov/Archives/edgar/data/2158834/000215883426000001/primary_doc.xml", | |
| "quote": "submissionType D; industryGroupType Biotechnology; issuerAddress city NATICK MA; totalAmountSold 1000000; dateOfFirstSale 2026-09-01" | |
| }, | |
| { | |
| "kind": "other", | |
| "url": "https://efts.sec.gov/LATEST/search-index?q=%22Biotechnology%22&forms=D&dateRange=custom&startdt=2026-10-26&enddt=2026-11-10", | |
| "quote": "hit 0002158834-26-000001: form D, file_date 2026-10-30" | |
| } | |
| ], | |
| "single_source_fields": [ | |
| "amount sold usd", | |
| "first sale" | |
| ], | |
| "single_source_reason": "Only the Form D itself states amount sold and first-sale date; EFTS confirms form type, filing date and issuer, not amounts." | |
| }, | |
| { | |
| "company": "AI3 Bio, Inc.", | |
| "city": "Watertown", | |
| "state": "MA", | |
| "amount sold usd": 48339490, | |
| "first sale": "2026-06-09", | |
| "filed on": "2026-11-04", | |
| "securities": "equity", | |
| "EDGAR link": "https://www.sec.gov/Archives/edgar/data/2019875/000201987526000003/0002019875-26-000003-index.htm", | |
| "sources": [ | |
| { | |
| "kind": "primary", | |
| "url": "https://www.sec.gov/Archives/edgar/data/2019875/000201987526000003/primary_doc.xml", | |
| "quote": "submissionType D; industryGroupType Biotechnology; issuerAddress city Watertown MA; totalAmountSold 48339490; dateOfFirstSale 2026-06-09" | |
| }, | |
| { | |
| "kind": "other", | |
| "url": "https://efts.sec.gov/LATEST/search-index?q=%22Biotechnology%22&forms=D&dateRange=custom&startdt=2026-10-26&enddt=2026-11-10", | |
| "quote": "hit 0002019875-26-000003: form D, file_date 2026-11-04" | |
| } | |
| ], | |
| "single_source_fields": [ | |
| "amount sold usd", | |
| "first sale" | |
| ], | |
| "single_source_reason": "Only the Form D itself states amount sold and first-sale date; EFTS confirms form type, filing date and issuer, not amounts." | |
| }, | |
| { | |
| "company": "Zai Lab Ltd", | |
| "city": "Cambridge", | |
| "state": "MA", | |
| "amount sold usd": 249933600, | |
| "first sale": "2026-10-27", | |
| "filed on": "2026-11-09", | |
| "securities": "equity", | |
| "EDGAR link": "https://www.sec.gov/Archives/edgar/data/1704292/000170429226000038/0001704292-26-000038-index.htm", | |
| "sources": [ | |
| { | |
| "kind": "primary", | |
| "url": "https://www.sec.gov/Archives/edgar/data/1704292/000170429226000038/primary_doc.xml", | |
| "quote": "submissionType D; industryGroupType Biotechnology; issuerAddress city CAMBRIDGE MA; totalAmountSold 249933600; dateOfFirstSale 2026-10-27" | |
| }, | |
| { | |
| "kind": "other", | |
| "url": "https://efts.sec.gov/LATEST/search-index?q=%22Biotechnology%22&forms=D&dateRange=custom&startdt=2026-10-26&enddt=2026-11-10", | |
| "quote": "hit 0001704292-26-000038: form D, file_date 2026-11-09" | |
| } | |
| ], | |
| "single_source_fields": [ | |
| "amount sold usd", | |
| "first sale" | |
| ], | |
| "single_source_reason": "Only the Form D itself states amount sold and first-sale date; EFTS confirms form type, filing date and issuer, not amounts. `funding recent` independently reports the same amount and first sale." | |
| }, | |
| { | |
| "company": "ABVC BioPharma, Inc.", | |
| "city": "Fremont", | |
| "state": "CA", | |
| "amount sold usd": 3387500, | |
| "first sale": "2026-10-30", | |
| "filed on": "2026-11-10", | |
| "securities": "debt", | |
| "EDGAR link": "https://www.sec.gov/Archives/edgar/data/1173313/000121390026118072/0001213900-26-118072-index.htm", | |
| "sources": [ | |
| { | |
| "kind": "primary", | |
| "url": "https://www.sec.gov/Archives/edgar/data/1173313/000121390026118072/primary_doc.xml", | |
| "quote": "submissionType D; industryGroupType Biotechnology; issuerAddress city FREMONT CA; totalAmountSold 3387500; dateOfFirstSale 2026-10-30" | |
| }, | |
| { | |
| "kind": "other", | |
| "url": "https://efts.sec.gov/LATEST/search-index?q=%22Biotechnology%22&forms=D&dateRange=custom&startdt=2026-10-26&enddt=2026-11-10", | |
| "quote": "hit 0001213900-26-118072: form D, file_date 2026-11-10" | |
| } | |
| ], | |
| "single_source_fields": [ | |
| "amount sold usd", | |
| "first sale" | |
| ], | |
| "single_source_reason": "Only the Form D itself states amount sold and first-sale date; EFTS confirms form type, filing date and issuer, not amounts." | |
| }, | |
| { | |
| "company": "Chickadee Biomedicines, Inc.", | |
| "city": "New York", | |
| "state": "NY", | |
| "amount sold usd": 1000000, | |
| "first sale": "2026-10-28", | |
| "filed on": "2026-11-10", | |
| "securities": "option / security to be acquired / other", | |
| "EDGAR link": "https://www.sec.gov/Archives/edgar/data/2138882/000213888226000003/0002138882-26-000003-index.htm", | |
| "sources": [ | |
| { | |
| "kind": "primary", | |
| "url": "https://www.sec.gov/Archives/edgar/data/2138882/000213888226000003/primary_doc.xml", | |
| "quote": "submissionType D; industryGroupType Biotechnology; issuerAddress city NEW YORK NY; totalAmountSold 1000000; dateOfFirstSale 2026-10-28" | |
| }, | |
| { | |
| "kind": "other", | |
| "url": "https://efts.sec.gov/LATEST/search-index?q=%22Biotechnology%22&forms=D&dateRange=custom&startdt=2026-10-26&enddt=2026-11-10", | |
| "quote": "hit 0002138882-26-000003: form D, file_date 2026-11-10" | |
| } | |
| ], | |
| "single_source_fields": [ | |
| "amount sold usd", | |
| "first sale" | |
| ], | |
| "single_source_reason": "Only the Form D itself states amount sold and first-sale date; EFTS confirms form type, filing date and issuer, not amounts. `funding recent` independently reports the same amount and first sale." | |
| } | |
| ], | |
| "frozen": "2026-11-12" | |
| } |